Short procedure of GHRH plus arginine test in clinical practice
- PMID: 12138985
- DOI: 10.1023/a:1015306705154
Short procedure of GHRH plus arginine test in clinical practice
Abstract
Either in children or in adults, arginine (ARG) alone and combined with GHRH (GHRH+ARG) are reliable tests for the diagnosis of GH deficiency. The procedures of these tests generally include GH measurement every 15 min from baseline up to 90-120 min. Aim of our study was to verify if the procedure of these tests could be usefully shortened in clinical practice. To this goal we have studied 173 normally growing children and adolescents (C, 117 M and 56 F, age: 11.3 +/- 0.4 yr.) and 125 young and middle aged normal adults (A, 68 M and 57 F, age: 30.0 +/- 0.6 yr.). ARG alone test was performed by 81 C and 33 A (0.5 g/kg arginine, i.v., from 0 to +30 min, up to a maximum of 30 g) while GHRH (1 microg/kg i.v. bolus at 0 min) + ARG test was performed by 92 C and 92 A. After ARG alone, taking into account data from +15 to +105 min, GH values above the 3rd centile limit of arbitrary cut-off (7 or 10 microg/l in C and 5 microg/l in A) occurred in 85% or 64% and 94% subjects, respectively. After GHRH+ARG test, taking into account only data at +30, +45, +60 min GH values above the 3rd centile limit (20 microg/l in C and 16.5 microg/l in A) occurred in 99% of subjects in both groups. Taking into account only these 3 timing points, the percentage of GH peak above the third centile limits after ARG alone was never higher than 60% in C and 85% in A. In conclusion, this study shows that single GHRH+arginine test can be reliably performed in a shortened procedure which makes easier the clinical practice and further reduces costs.
Similar articles
-
Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.J Clin Endocrinol Metab. 2000 Oct;85(10):3693-9. doi: 10.1210/jcem.85.10.6858. J Clin Endocrinol Metab. 2000. PMID: 11061526 Clinical Trial.
-
Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.J Clin Endocrinol Metab. 2001 Apr;86(4):1574-9. doi: 10.1210/jcem.86.4.7394. J Clin Endocrinol Metab. 2001. PMID: 11297586
-
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.J Clin Endocrinol Metab. 1998 May;83(5):1615-8. doi: 10.1210/jcem.83.5.4837. J Clin Endocrinol Metab. 1998. PMID: 9589665
-
Retesting the childhood-onset GH-deficient patient.Eur J Endocrinol. 2008 Dec;159 Suppl 1:S45-52. doi: 10.1530/EJE-08-0293. Epub 2008 Sep 19. Eur J Endocrinol. 2008. PMID: 18805914 Review.
-
Update on the diagnosis of GH deficiency in adults.Eur J Endocrinol. 2003 Apr;148 Suppl 2:S3-8. doi: 10.1530/eje.0.148s003. Eur J Endocrinol. 2003. PMID: 12670294 Review.
Cited by
-
A single growth hormone determination 30 minutes after the administration of the GHRH plus GHRP-6 test is sufficient for the diagnosis of somatotrope dysfunction in patients who have suffered traumatic brain injury.J Endocrinol Invest. 2007 Mar;30(3):224-9. doi: 10.1007/BF03347429. J Endocrinol Invest. 2007. PMID: 17505156
-
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.J Clin Invest. 2006 Sep;116(9):2442-55. doi: 10.1172/JCI28658. Epub 2006 Aug 24. J Clin Invest. 2006. PMID: 16932809 Free PMC article.
-
Diagnosis of adult GH deficiency.Pituitary. 2008;11(2):121-8. doi: 10.1007/s11102-008-0110-x. Pituitary. 2008. PMID: 18404387 Review.
-
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency.Pituitary. 2024 Oct;27(5):480-487. doi: 10.1007/s11102-024-01406-y. Epub 2024 May 31. Pituitary. 2024. PMID: 38819617 Free PMC article.
-
The history of an effective, specific and sensitive diagnostic test: the GHRH test in clinical practice.Rev Endocr Metab Disord. 2025 Jun;26(3):353-369. doi: 10.1007/s11154-024-09938-1. Epub 2024 Dec 17. Rev Endocr Metab Disord. 2025. PMID: 39681762 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources